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ABSTRAK
Demam uap logam/metal fume fever (MFF) adalah sindroma demam inhalasi pada tukang las baja seng, yang 
menggabungkan dan memotong komponen-komponen logam dengan menggunakan lidah api atau percikan listrik 
dan sumber panas lainnya. Inhalasi oksida logam tertentu yang baru saja terbentuk akibat proses pengelasan 
dapat menyebabkan MFF sebagai suatu penyakit akut swasirna yang menyerupai flu (acute self-limiting flulike 
illness). Penyebab MFF yang paling umum adalah inhalasi seng oksida (ZnO). Inhalasi partikel ZnO dapat 
mencetuskan sejumlah respons klinis yang disertai oleh perubahan komposisi cairan bilasan bronkoalveolar/
bronchoalveolar lavage (BAL) fluid, yang meliputi peningkatan sitokin pro-inflamasi dini, penanda inflamasi 
dan rekrutmen sel-sel inflamasi di paru-paru. MFF ditandai oleh demam, batuk, pengeluaran dahak, mengi, 
sesak di dada, lelah, menggigil, demam, mialgia, batuk, dispnea, leukositosis dengan pergeseran ke kiri, rasa 
haus, rasa metalik dan salivasi. Diagnosis MFF didasarkan pada temuan klinis dan riwayat pekerjaan. Gejala 
menyembuh spontan. Pengobatan MFF sepenuhnya bersifat simptomatik, tidak ada pengobatan khusus yang 
diindikasikan untuk MFF. Tatalaksana utama MFF adalah pencegahan paparan selanjutnya dari unsur logam 
yang membahayakan; termasuk membangun kesadaran masyarakat dan para dokter tentang MFF agar dapat 
mengurangi tingkat kejadian penyakit ini.
Kata kunci: demam uap logam, seng oksida, inflamasi, pencegahan.
ABSTRACT
The metal fume fever (MFF) is an inhalation fever syndrome in welders of galvanized steel, who join and 
cut metal parts using flame or electric arc and other sources of heat. Inhalation of certain freshly formed metal 
oxides produced from welding process can cause MFF as an acute self-limiting flulike illness. The most common 
cause of MFF is the inhalation of zinc oxide (ZnO). The inhalation of ZnO particles can provoke a number of 
clinical responses of which accompanied by changes in composition of bronchoalveolar lavage (BAL) fluid, 
including early increase in pro-inflammatory cytokines, inflammatory marker, and recruitment of inflammatory 
cells in the lungs. The MFF is characterized by fever, cough, sputing, wheezing, chest tightness, fatique, chills, 
fever, myalgias, cough, dyspnea, leukocytosis with a left shift, thirst, metallic taste, and salivations. The diagnosis 
of MFF diagnosis is based on clinical finding and occupational history. The symptoms resolved spontaneously. 
The treatment of MFF is entirely symptomatic, no specific treatment is indicated for MFF. The mainstay of 
management of MFF is prevention of sub-sequent exposure to harmful metals. Including public and physician 
awareness of MFF may help to reduce the occurrence of the disease.
Key words: metal fume fever, zinc oxide, inflammation, prevention.
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INTRODUCTION
Metal fume fever (MFF) is an inhalation 
fever syndrome long recognized in metal 
workers. It was first described in the mid-1800 
as brass founders’ ague in brass foundry workers, 
and in 1900s in welders of galvanized steel (the 
metallurgical combination of zinc and steel as 
the corrosion protection), particularly in the 
shipyard industry.1 The international standard 
classification of occupations (ISCO) defined 
welders are workers who join and cut metal parts 
using flame or electric arc and other sources of 
heat.2 Inhalation of certain freshly formed metal 
oxides, produced from welding process, can 
cause MFF, an acute self-limiting flulike illness.
The most common cause of MFF is the 
inhalation of ZnO, which is generated from 
molten bronze or welding galvanized steel.3 It 
is estimated that more than 700,000 workers 
in the United States are involved in welding 
operations, so the potential for inhalational 
exposure and MFF is great. An estimated 
minimum of 1,500-2,000 cases of MFF occur 
each year in the United States.4,5 A prevalence 
of 31% for MFF and a prevalence of over 35% 
was reported, but an exact definition was not 
provided.5 When zinc is heated to its melting 
point, zinc oxide fumes are generated, The 
particle size of the generated fumes ranges from 
0.1-1.0 μm in diameter, although aggregation 
with the formation of larger particles occurs 
readily. The underlying pathogenesis of MFF 
is not completely understood, although there 
is evidence from controlled human exposure 
studies that zinc oxide fume inhalation induces 
leukocytes recruitment to the lungs with an 
associated release cytokines, which causes 
systemic symptoms.3
The diagnosis of MFF is based on clinical 
finding and occupational history. The symptoms 
resolved spontaneously. The MFF linked with 
inhalation of fumes of ZnO is characterized by 
fever, cough, sputing, wheezing, chest tightness, 
fatique, chills, fever, myalgias, cough, dyspnea, 
leukocytosis with a left shift, thirst, metallic 
taste, and salivations. The treatment of MFF 
is entirely symptomatic, no specific treatment 
is indicated for MFF.5-7 Prevention relies on 
appropriate engineering controls and/or personal 
protective equipment to reduce exposure. There 
are no good data on the long term sequelae of 
repeated exposures.3
PATHOGENESIS
The ZnO is a common constituent of 
particulate air pollution and if inhaled in fine or 
ultra-fine fractions with a particle size smaller 
than 0.5μ-1μ and at a concentration exceeding 
500 μg/m3 for 2 hours can induce acute systemic 
effects.6 A severe acute inflammation of 
peripheral bronchoalveolar structures following 
zinc fume is sign by a distinct increase of the total 
cell count and number of the polymorphonuclear 
(PMN) leukocytes. There are several hypothesis 
of the MFF’s pathogenesis, such as the release of 
endogenous pyrogens from leukocytes, and the 
production of metal proteinases (composed of 
the inhaled particles and the damaged pulmonary 
tissue) that are recognized as antigens and lead 
to the formation of allergen-antibody complexes 
which cause the clinical symptoms, but the 
precise mechanism is still un-clear.6,7
Inhalation of ZnO particles can provoke 
a number of clinical responses of which 
accompanied by changes in composition of 
BAL fluid, including early increase in tumor 
necrosis (TNF)-α followed by interleukine (IL)-
8 and IL-6, matrix metalloproteinase (MMP)-9, 
myeloperoxydase (MO), α2-macroglobulin 
levels, and numbers of PMN. There is also an 
increase in C-reactive protein (CRP) in blood.6,8 
The cytokine networking mediated by the release 
of pro-inflammatory cytokines by pulmonary 
macrophages causes both local pulmonary 
inflammatory cellular (neutrophils recruitment) 
and systemic response, and also increased of 
reactive oxygen species (ROS) production.9 The 
IL-8 level peaked at 8 hours whereas IL-6 value 
steadily increased with the time after exposure 
and reached a maximum concentration at 22 
hours. The TNF-α level is elevated as soon 
as 3 hours after exposure, and it plays a large 
role in the initial response of MFF, whereas 
IL-6 and IL-8 are likely involved in the later 
response. The TNF-α also has been shown to 
induce IL-8 production.6,10 The mechanism by 
which zinc may induce cell signaling, nuclear 
translocation of nuclear factors in the cytokines 
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production, is not clear. It is postulated that zinc-
induced pulmonary inflammation may involve 
endothelial growth factor receptor-mediated 
activation of mitogen-activated protein kinase 
(MAPK).11
The ZnO contained in the welding fume is 
likely to be deposited in the bronchiolar and 
alveolar regions of the lungs, and will generate 
more free radical activity leading to oxidative 
stress, of which one pathway is the formation 
of ROS, and thus induce a greater inflammatory 
response.12 The high level of ROS cause a 
change in the redox status of the cell, thereby 
triggering a cascade of events associated with 
inflammation and, at higher concentrations, 
apoptosis. Typically ROS are formed in cells 
through the reduction of oxygen by biological 
reducing agents such as reduced nicotinamide 
adenine dinucleotide (NADH) and reduced 
nicotinamide adenine dinucleotide phosphate 
(NADPH).13 The oxidative stress is leading to 
activation of MAPK-dependent nuclear factor-
kappa beta (NF-κβ), protein kinase C (PKC), and 
activator protein (AP)-1 (Figure 1).10,14
The lung is an important source of 
inflammatory cytokines as well as the target 
organ for the effects of these mediators.14 The 
acute effects of the exposure to Zn results in 
activation of the extra-cellular signal-regulated 
kinase (ERK), c-Jun NH2-terminal kinase 
(JNK) as a member of AP-1, and p38 MAPK 
pathways.15 The MAPKs are an important 
group of serine or threonine signaling kinases 
that play a major role in converting mitogenic 
and stress stimuli into nuclear responses. Three 
major groups of MAPK have been identified. 
The ERK1 and ERK2 pathways transmit signals 
due to mitogenic and differentiation stimuli. The 
JNK and p38 pathways transmit stress signals 
resulting from oxidative stress or stimulation 
with inflammatory cytokines, such as TNF-α 
which may induce phosphorylation of p50 and 
p65 sub-units of NF-κβ. Activation of these 
signal transduction pathways leads to either 
phosphorylation of transcription factors in the 
nucleus or translocation of nuclear factors, such 


















Figure 1. The different components of different combustion-derived nanoparticles can cause oxidative 
stress that acts through well-documented redox-sensitive pathways, such as MAPK and NF-κB, to 
cause inflammation.14
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The activation of the p38 MAPK pathway 
is critical for many immune response-related 
functions, including T-cell differentiation and 
death, macrophage and neutrophils effector 
functions (e.g., respiratory burst, granular 
exocytosis, etc.), and the production of pro-
inflammatory cytokines including TNF-α. There 
are 4 isoforms of p38 MAPK: p38α, p38β, 
p38δ, and p38γ; and it seems that p38α and/or 
p38β is responsible for induction of TNF-α and 
IL-6 mRNA.17,18 The c-Jun and the activating 
transcription factor (ATF)-2 proteins are known 
targets of JNK kinase family members, and 
are phosphorylated on residues within the 
N-terminus trans-activation domain. The trans-
activation activation of  ATF-2, as a substrate for 
p38 MAPK, is regulated post-translationally by 
phosphorylation, particularly by the JNK and 
p38 group of MAPK, after exposure to cellular 
stress. The ATF-2 has also been implicated in 
mediating a transcriptional response to c-Jun 
promoter, and may interact with NF-κβ in a 
DNA-independent manner, leading to increase 
transcriptional activity.19,20 The ZnO exposure 
may increase the binding of p65 of the NF-κβ 
to IL-8 gene promoter and also increased the 
phosphorylation of p65 at ser276 and ser536.21,22
CLINICAL PRESENTATION 
The MFF has been defined as a “flulike” 
illness that develops after inhalation of metal 
fumes. The clinical symptoms of MFF begin 
in 3-10 hours after exposure to ZnO in welding 
fume. The workers develop tachyphylaxis, that 
is symptoms appear only when the exposure, 
not when there are regular repeated exposures.3,5 
Moreover, as MFF can be experienced on the 
first day by a new employee in the welding 
profession, without any latency, whereas airway 
obstruction and respiratory symptomatology 
require some latency periode, it is conceivable 
that MFF, occurring shortly after exposure, could 
be a risk factor for the further development of 
respiratory symptoms and/or increased bronchial 
responsiveness.5
Initially, there may be a sweet metallic taste 
in the mouth associated with throat irritation, 
accompanied by a worsening dry cough and 
shortness of breath. Fever and shaking chills 
often develop and the worker feels ill.3,5 The 
principle elements of the systemic symptoms 
according to the clinical description of MFF, 
included the following: history of a particular 
taste in the mouth (such as a sweet metallic 
taste), flue-like symptoms (such as fever, 
feeling of flue, general malaise, chills), myalgia, 
arthralgia, throat symptoms (such as dry, itchy, 
or constricted throat, dry cough, hoarness), 
digestive symptoms (such as loss of appetite, 
nausea, abdominal cramps), fatigue (such as 
weakness, yawning, difficulty concentrating), 
and history of respiratory symptoms (such as 
wheezing, chest tightness, shortness of breath, 
and cough).4 A case study of MFF in 25 year 
old male welder with MFF showed that he 
was suffering from aseptic meningitis with 
pericarditis, pleuritis, and pneumonia.6
DIAGNOSTIC PROCEDURES
The ZnO welding fumes were associated 
with a marked-dependent increase in the number 
of polymorphonuclear leukocytes recovered 
in BAL fluid in 22 hours following exposure, 
although it was not associated with a clinically 
significant change in pulmonary function or 
airway reactivity.6 In non-smokers, welding fume 
exposure was associated with a mean increase 
in white blood cell (WBC) count by 0.8 x 103/
μl. Likewise, neutrophil counts in non-smokers 
increased by 1.0 x 103/μl, indicating that the 
increase in WBC count following exposure may 
be mostly attributable to the increased neutrophil 
counts. The acute exposure to welding fume is 
associated with the increased levels of systemic 
inflammatory markers. Additionally, smoking 
is found to modify the effect of welding fume 
on specific inflammatory markers. Immediately 
following welding fume exposure, non-smokers 
experience a significant increase in circulating 
WBC counts, specifically absolute and relative 
neutrophil counts, and a significant decrease in 
fibrinogen level. Sixteen hours after exposure, 
both non-smokers and smokers will experience 
significantly increased levels of CRP.23
The chest roentgenogram of MFF is usually 
normal but may show bilateral pulmonary 
infiltrates.24 A study in New Zealand in 1996, 
found that an acute decrease in FEV1 was more 
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prevalent among welders than the comparison 
group of non-welders, and more common among 
welders without local exhaust ventilation.23 
Another study in Denmark between 1987 and 
2004 among 68 steel welders and 32 non-welding 
production workers, found that long-term 
exposure to welding emissions may accelerate 
the age-related decline of lung function but at 
exposure level levels in range of 1.5 to 6.5 mg/
m3 the average annual excess loss of  FEV1 is 
un-likely to exceed 25 ml in smokers and 10 ml 
in non-smokers.23,25
The definitive diagnosis of MFF is based 
on clinical findings and is confirmed by the 
occupational history combined with the rapid 
resolution of the symptoms which generally 
peak at 18 hours and resolve spontaneously 
with complete resolution of abnormalities within 
1-2 days.3,24 The differential diagnosis includes 
common respiratory viral diseases, inhalation 
injury from polymer fumes or smoke, and true 
chemical pneumonitis following exposure to 
fumes from cadmium, manganese, mercury, 
or nikel. In the later cases, the condition is 
progressive and sometimes complicated by non-
cardiogenic pulmonary edema.24
TREATMENT AND PREVENTION
The treatment of MFF is entirely symptomatic. 
The treatment including the control of elevated 
body temperature by anti-pyretics, analgetics, 
and oxygen therapy for hypoxemia may be 
required.3,24 The mainstay of management of 
MFF is prevention of sub-sequent exposure to 
harmful metals. Including public and physician 
awareness of MFF may help to reduce the 
occurrence of the disease.24
The respiratory protective devices are 
used in only 20-30% of the work situations 
where they are needed, and this was attributed 
to environmental conditions, physical work 
demands, psychological and social factors, and 
the individual characteristic of the wearer.26 
There is occupational exposure limits (OELs), 
as the maximum permissible concentration of 
a hazardous substance that most healthy adults 
may be repeatedly exposed to without suffering 
adverse health effects. There maybe increased 
risk, for example, for a smoker, a person with 
pre-existing health problems or individuals 
who suffer from allergies. The OELs are often 
assigned three values. One value is based on 
normal working conditions of 8 hours per day, 
over an average lifetime of exposure. If more 
than 8 hours are worked, this value must be 
adjusted. A second value provides a limit for 15 
minutes, short term exposure. This is a value to 
which a worker may be exposed for 15 minutes, a 
maximum of 4 times per shift, with at least 1 hour 
between exposures. In this case, the 8 hour OEL 
can not be exceeded. A third value is the ceiling 
limit. This limit must never be exceeded. If one 
or more than one type of contaminant is present, 
as in most welding situations, and the effects of 
exposure to each is similar, an exposure limit 
for the mixture is calculated. This value is lower 
than the limits set for exposure to individual 
contaminants. The amount of exposures are 
measure in parts-per-million (ppm) or milligrams 
per cubic meter (mg/m3), using sophisticated 
instruments and techniques.27
The ways to avoid hazard from welding, are 
by keeping the head out the fumes, do not breath 
the fumes, use enough ventilation, exhaust at the 
arch or both to keep fumes and gases from the 
breathing zone and the general area (Figure 2 and 
3), if adequacy of the ventilation or exhaust is 
un-certain or not used than approved respirators 
or air-supplied should be worn to remove the 
fumes from breathing zone, wear protective 
work clothing, and wash thoroughly immediately 
after exposure to ZnO.27,28 The steps to reduce 
the welding fumes and gases are by substituting 
less hazardous flux materials, introducing 
engineering control by using enclosures and 
improving ventilation, developing administrative 
controls, such as implementing work-rest, and 
wearing respiratory protection.28
There is need for proper education of 
this economically viable group on workplace 
hazards, the types and proper use of the different 
protective devices in order to safeguard the 
welders health. There is also need for a strong 
welder’s union that should make adequate 
and proper representation to the appropriate 
tier of government. The ministry of labour in 
conjunction with the ministry of health should 
collaborate to provide health care for this group 
Vol 46 • Number 3 • July 2014                                                               Metal fume fever among Galvanized welders
261
of workers, as close as possible to where they live 
and work, in keeping with one of the principles 
of the primary health programme.2
CONCLUSION
Metal fume fever (MFF) is a disease caused by 
inhalation of certain freshly formed metal oxides, 
most common cause is the inhalation of ZnO. It 
is an acute self-limiting flulike illness, marked 
by changes in composition of bronchoalveolar 
lavage (BAL) fluid, including early increase 
in pro-inflammatory cytokines, inflammatory 
marker, and recruitment of inflammatory cells in 
the lungs.It may be accompanied by leukocytosis 
and reduced in lung function, especially in those 
who have repeated exposure and smoking. The 
treatment of MFF is entirely symptomatic and 
rest. The mainstay of management of MFF is 
prevention of sub-sequent exposure to harmful 
metals. Including public and physician awareness 
of MFF may help to reduce the occurrence of 
the disease.
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